首页 > 市场调查报告书 > 製药

麻醉

市场调查报告书

商品编码

2008144

局部麻醉剂市场：依药物类型、给药途径及地区划分

Local Anesthesia Drugs Market, By Drug Type, By Mode Of Administration, By Geography

出版日期: 2026年03月17日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026年局部麻醉剂市场规模估计为53亿美元，预计2033年将达87亿美元。预计2026年至2033年，该市场将以4.1%的复合年增长率成长。

分析范围		分析详情
基准年	2025	市场规模（2026 年）	53亿美元
效能数据	2020-2024	预测期	2026-2033
预测期（2026-2033 年）复合年增长率	4.10%	预计金额（2033 年）	87亿美元

局部麻醉是一种使用局部麻醉剂来麻痹身体特定部位的治疗方法。它是一种镇痛方式，用于在小型手术中麻痹易痛的小区域。使用长效局部麻醉剂可以延长神经阻断麻醉的效果。局部麻醉剂用于治疗疼痛症状、预防手术或手术过程中的疼痛，或缓解术后疼痛。与全身麻醉剂相比，局部麻醉剂使用起来更安全，副作用也更少。

市场动态

手术数量的增加以及术后镇痛中局部麻醉剂的广泛应用，正在推动局部局部麻醉剂的成长，预计这一趋势将在预测期内持续。例如，根据美国整形外科麻醉剂协会的数据，2020年美国共进行了超过680万例重组手术、1,320万例微创美容手术和约230万例美容手术。

此外，2021 年 5 月，美国食品药物管理局(FDA)核准了首个缓释双效局部麻醉剂，即Bupivacaine和美洛昔康的组合，用于疼痛管理。

本报告的主要特点

本报告指出了各个细分市场的潜在商机，并概述了该市场中一系列有吸引力的投资提案。
此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本节根据以下参数介绍全球局部麻醉剂市场的主要企业概况：公司概况、产品系列、主要亮点、财务绩效和策略。
本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
《全球局部麻醉剂市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球局部麻醉剂市场中使用的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2025	Market Size in 2026:	USD 5.3 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.10%	2033 Value Projection:	USD 8.7 Bn

Local anaesthesia involves numbing an area of the body using a type of medicine called a local anaesthetic. It is a type of pain control used during minor procedures to numb small area where the pain is likely to occur. The use of long-acting local anesthetic prolongs the anesthetic effect of regional anesthesia. Local anesthesia drugs can be used to treat painful conditions, prevent pain during a procedure or operation, or relieve pain after surgery. Local anesthetics are much safer to use, but have fewer side effects compared to general anesthetics.

Market Dynamics

Increasing use of local anesthesia drugs across the globe due to increase in number of surgeries and increasing use of local anesthetic for post-operative pain is expected to augment the growth of the global local anesthesia drugs market over the forecast period. For instance, according to the American Society of Plastic Surgeons, in 2020, over 6.8 million reconstructive procedures, 13.2 million cosmetic minimally invasive procedures, and around 2.3 million cosmetic surgical procedures were performed in the United States.

Moreover, in May 2021, the Food and Drug Administration (FDA) approved the first extended-release dual acting local anesthetic of bupivacaine and meloxicam for pain management.

Key features of the study

This report provides in-depth analysis of the global local anesthesia drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global local anesthesia drugs market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global local anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global local anesthesia drugs market.

Market Segmentation

By Drug Type
- Bupivacaine
- Lidocaine
- Benzocaine
- Ropivacaine
- Prilocaine
- Chloroprocaine
- Others
By Mode Of Administration
- Injectable
- Surface Anesthetic
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Septodont
- Pfizer Inc.
- Pacira BioSciences, Inc.
- Braun Melsulgen AG
- Glenmark Pharmaceutical Ltd.
- Fresenius SE & Co. KgaA
- Hikma Pharmaceuticals PLC
- Teva Pharmaceutical Industries Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Nasal Drug Delivery Mode, By Drug Type
- Market Nasal Drug Delivery Mode, By Mode of Administration
- Market Nasal Drug Delivery Mode, By Geography
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increase in number of surgeries worldwide
- Side effects of anesthetic drugs
- Growing use of local anesthetic drugs
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Local Anesthesia Drugs Market, By Drug Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Bupivacaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Lidocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Benzocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ropivacaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Prilocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Chloroprocaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Local Anesthesia Drugs Market, By Mode of Administration, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Surface Anesthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Local Anesthesia Drugs Market, By Geography, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Countries
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
- Countries
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
South Africa
North Africa
Central Africa

7. Competitive Landscape

Septodont
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacira BioSciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Braun Melsulgen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Glenmark Pharmaceutical Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius SE & Co. KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

8. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

局部麻醉剂市场：依药物类型、给药途径及地区划分

Local Anesthesia Drugs Market, By Drug Type, By Mode Of Administration, By Geography

市场动态

目录

第一章：分析目标与假设

第二章市场展望

第三章：市场动态、监管与趋势分析

第四章：局部麻醉剂市场：依药物类型划分（2026-2033 年）

第五章：局部麻醉剂市场：依给药途径划分（2026-2033 年）

第六章：局部麻醉剂市场：按地区划分（2026-2033 年）

第七章竞争情势

第八章